PRESS-RELEASE ·Filed Mar 24, 2026
Press release: earnings
Actionable Insight • Neutral
Await full 8-K or earnings call for actual financial performance details. Lack of disclosed metrics suggests possible weakness or strategic omission.
Final — all horizons settled through T+60d
TELA ▲ +19.57% at T+60d
NEUTRAL call ✓ call won +19.57% · α vs SPY +6.11% · entry $0.6900 → $0.8250
T+1d
+8.12%
call +8.12% · α +9.89%
$0.7460
settled 6mo ago
T+5d
-17.54%
call -17.54% · α -17.29%
$0.5690
settled 6mo ago
T+20d
-9.86%
call -9.86% · α -17.72%
$0.6220
settled 5mo ago
T+60d
+19.57%
call +19.57% · α +6.11%
$0.8250
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
TELA Bio reported financial results for Q4 and full year 2025. The press release announces earnings but contains no actual financial figures such as revenue, EPS, or guidance, limiting actionable insights.
Key Facts
- TELA Bio released financial results for Q4 and full year 2025.
- No quantitative financial data (revenue, EPS, margins, guidance) was disclosed in the provided text.
- Company described as commercial-stage with focus on soft-tissue reconstruction solutions.
Financial Impact
Insufficient data to determine financial impact
Risk Factors
- Material financial figures not disclosed in press release, raising transparency concerns.
- Potential for negative market reaction if results were materially weak.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3261734 |
12 reports for TELA
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $0.7380 $1.24 | ▲ +68.02% | ▲ +68.21% | $1.19 (+61.25%) |
Aug 10, 2026 7w ago | 8-K | $0.7900 $0.9113 | ▼ −15.35% | ▼ −16.41% | $1.19 (−50.63%) |
Jun 11, 2026 16w ago | 3 | $0.8600 $0.8470 | ▼ −1.51% | ▼ −3.29% | $1.19 (+38.37%) |
Jun 11, 2026 16w ago | 3 | $0.8600 $0.8470 | ▼ −1.51% | ▼ −3.29% | $1.19 (+38.37%) |
Jun 11, 2026 16w ago | 3 | $0.8600 $0.8470 | ▼ −1.51% | ▼ −3.29% | $1.19 (+38.37%) |
Jun 11, 2026 16w ago | 3 | $0.8600 $0.8470 | ▼ −1.51% | ▼ −3.29% | $1.19 (+38.37%) |
May 12, 2026 20w ago | 8-K | $0.9600 $0.9120 | ▼ −5.00% | ▼ −4.39% | $1.19 (+23.96%) |
May 12, 2026 20w ago | Press Release | $0.9600 $0.9120 | ▲ +5.00% | ▲ +4.39% | $1.19 (−23.96%) |
Apr 30, 2026 22w ago | 8-K | $0.9890 $0.9000 | ▼ −9.00% | ▼ −14.28% | $1.19 (+20.32%) |
Apr 21, 2026 23w ago | Press Release | $0.6250 $0.8600 | ▲ +37.60% | ▲ +34.43% | $1.19 (+90.40%) |
Showing 10 of 12
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access